Stay updated on Prophylactic Emicizumab in Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Prophylactic Emicizumab in Hemophilia A Clinical Trial page.

Latest updates to the Prophylactic Emicizumab in Hemophilia A Clinical Trial page
- Check7 days agoChange Detected- Revision updated from v3.5.2 to v3.5.3 to reflect an update to the page’s version; it does not alter the study details or content.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.5.2 added; Revision: v3.5.0 removed.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedAdded 'Hereditary factor VIII deficiency disease' as a related disease term and included a link to the Genetic and Rare Diseases Information Center (GRDR) for further information.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.5.0 added; Hemophilia A and the Genetic and Rare Diseases Information Center resource were removed (previous revision v3.4.3 also removed).SummaryDifference0.1%

- Check57 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check85 days agoChange DetectedRevision: v3.4.2 was added to the page and the funding lapse notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Prophylactic Emicizumab in Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prophylactic Emicizumab in Hemophilia A Clinical Trial page.